19.10.2015 Views

Global Pressure Ulcers Clinical Trials Review Market Analysis Report 2015 Radiant Insights, Inc

Summary GlobalData's clinical trial report, "Pressure Ulcers Global Clinical Trials Review, H1, 2015" provides an overview of Pressure Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Pressure Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. Access This Full Report @ http://www.radiantinsights.com/research/pressure-ulcers-global-clinical-trials-review-h1-2015 The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level

Summary
GlobalData's clinical trial report, "Pressure Ulcers Global Clinical Trials Review, H1, 2015" provides an overview of Pressure Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Pressure Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Access This Full Report @ http://www.radiantinsights.com/research/pressure-ulcers-global-clinical-trials-review-h1-2015
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Global</strong> <strong>Pressure</strong> <strong>Ulcers</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Analysis</strong><br />

<strong>Report</strong> <strong>2015</strong>: <strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Summary<br />

<strong>Global</strong>Data's clinical trial report, "<strong>Pressure</strong> <strong>Ulcers</strong> <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>" provides an<br />

overview of <strong>Pressure</strong> <strong>Ulcers</strong> clinical trials scenario. This report provides top line data relating to the<br />

clinical trials on <strong>Pressure</strong> <strong>Ulcers</strong>. <strong>Report</strong> includes an overview of trial numbers and their average<br />

enrollment in top countries conducted across the globe. The report offers coverage of disease clinical<br />

trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. <strong>Report</strong> also<br />

provides prominent drugs for in-progress trials (based on number of ongoing trials). <strong>Global</strong> Data <strong>Clinical</strong><br />

Trial <strong>Report</strong>s are generated using <strong>Global</strong> Data's proprietary database - Pharma eTrack <strong>Clinical</strong> trials<br />

database. <strong>Clinical</strong> trials are collated from 80+ different clinical trial registries, conferences, journals, news<br />

etc across the globe. <strong>Clinical</strong> trials database undergoes periodic update by dynamic process.<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

The report enhances the decision making capabilities and helps to create an effective counter strategies to<br />

gain competitive advantage.<br />

Scope<br />

- The report provides a snapshot of the global clinical trials landscape<br />

- <strong>Report</strong> provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status,<br />

Trial Phase, Sponsor Type and End point status<br />

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining<br />

to the company<br />

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason<br />

for unaccomplishment<br />

- The <strong>Report</strong> provides enrollment trends for the past five years<br />

- <strong>Report</strong> provides latest news for the past three months<br />

Reasons to buy<br />

- Assists in formulating key business strategies with regards to investment<br />

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost


- Provides top level analysis of <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong> which helps in identifying key business<br />

opportunities<br />

- Supports understanding of trials count and enrollment trends by country in global therapeutics market<br />

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed<br />

and uncompleted (terminated, suspended or withdrawn) trials<br />

- Facilitates clinical trial assessment of the indication on a global, regional and country level<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 4<br />

List of Figures 5<br />

Introduction 6<br />

<strong>Pressure</strong> <strong>Ulcers</strong> 6<br />

<strong>Report</strong> Guidance 6<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Clinical</strong> <strong>Trials</strong> by Region 7<br />

<strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Country 8<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Asia-Pacific 10<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Europe 11<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in North America 12<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Middle East and Africa 13<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Central and South America 14<br />

<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong> 15<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 16<br />

<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 17<br />

<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong> 18<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in E7 Countries 19


<strong>Clinical</strong> <strong>Trials</strong> in E7 Countries by Trial Status 20<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase 21<br />

In Progress <strong>Trials</strong> by Phase 22<br />

<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 23<br />

<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 24<br />

Unaccomplished <strong>Trials</strong> of <strong>Pressure</strong> <strong>Ulcers</strong> 25<br />

Subjects Recruited Over a Period of Time 28<br />

<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 29<br />

Prominent Sponsors 30<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

Top Companies Participating in <strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 31<br />

Prominent Drugs 32<br />

<strong>Clinical</strong> Trial Profiles 33<br />

<strong>Clinical</strong> Trial Overview of Top Companies 33<br />

Smith & Nephew Plc 33<br />

<strong>Clinical</strong> Trial Overview of Smith & Nephew Plc 33<br />

Nitta Gelatin India Limited 34<br />

<strong>Clinical</strong> Trial Overview of Nitta Gelatin India Limited 34<br />

Abbott Laboratories 35<br />

<strong>Clinical</strong> Trial Overview of Abbott Laboratories 35<br />

NB Therapeutics, <strong>Inc</strong>. 36<br />

<strong>Clinical</strong> Trial Overview of NB Therapeutics, <strong>Inc</strong>. 36<br />

Kyowa Hakko Europe GmbH 37<br />

<strong>Clinical</strong> Trial Overview of Kyowa Hakko Europe GmbH 37<br />

Cristalia Produtos Quimicos Farmaceuticos Ltda. 38


<strong>Clinical</strong> Trial Overview of Cristalia Produtos Quimicos Farmaceuticos Ltda. 38<br />

Changi General Hospital Pte Ltd 39<br />

<strong>Clinical</strong> Trial Overview of Changi General Hospital Pte Ltd 39<br />

Aurous HealthCare Research and Development India Private Limited 40<br />

<strong>Clinical</strong> Trial Overview of Aurous HealthCare Research and Development India Private Limited 40<br />

Andaluz Health Service 41<br />

<strong>Clinical</strong> Trial Overview of Andaluz Health Service 41<br />

ACR Biologics, LLC 42<br />

<strong>Clinical</strong> Trial Overview of ACR Biologics, LLC 42<br />

<strong>Clinical</strong> Trial Overview of Top Institutes / Government 43<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

Tehran University of Medical Sciences 43<br />

<strong>Clinical</strong> Trial Overview of Tehran University of Medical Sciences 43<br />

Hospital Universitario Central de Asturias 44<br />

<strong>Clinical</strong> Trial Overview of Hospital Universitario Central de Asturias 44<br />

U.S. Department of Veterans Affairs 45<br />

<strong>Clinical</strong> Trial Overview of U.S. Department of Veterans Affairs 45<br />

Basque Health Service 46<br />

<strong>Clinical</strong> Trial Overview of Basque Health Service 46<br />

Bayside Health 47<br />

<strong>Clinical</strong> Trial Overview of Bayside Health 47<br />

Central Arkansas Veterans Healthcare System 48<br />

<strong>Clinical</strong> Trial Overview of Central Arkansas Veterans Healthcare System 48<br />

China Medical University Hospital 49<br />

<strong>Clinical</strong> Trial Overview of China Medical University Hospital 49


Department of Health, South Africa 50<br />

<strong>Clinical</strong> Trial Overview of Department of Health, South Africa 50<br />

Ghent University 51<br />

<strong>Clinical</strong> Trial Overview of Ghent University 51<br />

Higashi Washinomiya Hospital 52<br />

<strong>Clinical</strong> Trial Overview of Higashi Washinomiya Hospital 52<br />

Five Key <strong>Clinical</strong> Profiles 53<br />

Appendix 69<br />

Abbreviations 69<br />

Definitions 69<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

Research Methodology 70<br />

Secondary Research 70<br />

About <strong>Global</strong>Data 71<br />

Contact Us 71<br />

Disclaimer 71<br />

Source 71<br />

List of Tables<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries, <strong>2015</strong>* 10<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12


<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries, <strong>2015</strong>* 13<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central and South America, Top Countries, <strong>2015</strong>* 14<br />

Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 21<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 22<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, Suspended <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 25<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, Withdrawn <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 26<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, Terminated <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 27<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target Trends, 2010-2014 28<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 29<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 30<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 31<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>*<br />

32<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Smith & Nephew Plc,<br />

<strong>2015</strong>* 33<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Nitta Gelatin India<br />

Limited, <strong>2015</strong>* 34


<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Abbott Laboratories,<br />

<strong>2015</strong>* 35<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by NB Therapeutics, <strong>Inc</strong>.,<br />

<strong>2015</strong>* 36<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Kyowa Hakko Europe<br />

GmbH, <strong>2015</strong>* 37<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Cristalia Produtos<br />

Quimicos Farmaceuticos Ltda., <strong>2015</strong>* 38<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Changi General Hospital<br />

Pte Ltd, <strong>2015</strong>* 39<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Aurous HealthCare<br />

Research and Development India Private Limited, <strong>2015</strong>* 40<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Andaluz Health Service,<br />

<strong>2015</strong>* 41<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ACR Biologics, LLC,<br />

<strong>2015</strong>* 42<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Tehran University of<br />

Medical Sciences, <strong>2015</strong>* 43<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Hospital Universitario<br />

Central de Asturias, <strong>2015</strong>* 44<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by U.S. Department of<br />

Veterans Affairs, <strong>2015</strong>* 45<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Basque Health Service,<br />

<strong>2015</strong>* 46<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Bayside Health, <strong>2015</strong>* 47<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Central Arkansas Veterans<br />

Healthcare System, <strong>2015</strong>* 48<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by China Medical University<br />

Hospital, <strong>2015</strong>* 49


<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Department of Health,<br />

South Africa, <strong>2015</strong>* 50<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Ghent University, <strong>2015</strong>*<br />

51<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Higashi Washinomiya<br />

Hospital, <strong>2015</strong>* 52<br />

List of Figures<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries (%), <strong>2015</strong>* 13<br />

Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Pressure</strong> <strong>Ulcers</strong> to Dermatology <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 21<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 22<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24


<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target Trends, 2010-2014 28<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 29<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 30<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 31<br />

<strong>Pressure</strong> <strong>Ulcers</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>*<br />

32<br />

<strong>Global</strong>Data Methodology 70<br />

Access This Full <strong>Report</strong> @ http://www.radiantinsights.com/research/pressure -ulcers-globalclinical-trials-review-h1-<strong>2015</strong><br />

About <strong>Radiant</strong> <strong>Insights</strong><br />

<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking to meet their market research and business<br />

intelligence requirements. We assist and facilitate organizations and individuals procure market research<br />

reports, helping them in the decision making process. We have a comprehensive collection of reports,<br />

covering over 40 key industries and a host of micro markets. In addition to over extensive database of<br />

reports, our experienced research coordinators also offer a host of ancillary services such as, research<br />

partnerships/ tie-ups and customized research solutions.<br />

For More Information, Visit <strong>Radiant</strong> <strong>Insights</strong><br />

Contact:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@radiantinsights.com<br />

Blog URL: http://www.radiantinsightsinc.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!